Navigation Links
Carnegie Mellon's Yoed Rabin receives grants

PITTSBURGHCarnegie Mellon University's Yoed Rabin has received three grants totaling $1.26 million from the National Institutes of Health (NIH) to develop biothermal technology for low temperature applications ranging from cryopreservation to cryosurgery. Cryopreservation is the preservation of tissues and organs at very low temperatures with potential benefit to transplantation and regenerative medicine, whereas cryosurgery is the controlled destruction of undesired tissues by freezing, such as cancerous tumors.

"Ice crystallization is the cornerstone of tissue injury at low temperatures, where the outcome of cryogenic exposure is essentially related to the ability to control the formation of ice,''said Rabin, a mechanical engineering professor at Carnegie Mellon.

A promising method for cryopreservation is known as vitrification (glassy), where ice formation is prevented, and the tissue transforms into a complex glassy material.

"Unfortunately, common materials to promote glass formation are very toxic to the tissue, and the development of less harmful materials represents a major effort at the forefront of cryopreservation research,'' said Rabin.

With support of one NIH grant, Rabin is investigating the effects of combining exotic compounds known as synthetic ice blockers with common glass-promoting materials, in an effort to achieve vitrification in more favorable conditions to the tissue.

Through support of a second NIH grant. Rabin is developing a device to visualize the effects associated with cryopreservation, such as glass formation, crystallization and structural changes.

"Contrary to cryopreservation, ice formation is the key to cryosurgery success,'' said Rabin.

And with support of a third NIH grant, Rabin is leading a team effort to develop wireless, implantable temperature sensors, to assist in temperature monitoring and control of the cryosurgical procedure. The sensors would be strategically placed through a hypodermic needle prior to the operation, and communicate with a wireless server during the operation, in an effort to generate the developing 3D temperature field in the tissue in real time.

"While the wireless temperature sensor is being developed for cryosurgery, it can also be used to monitor and control cryopreservation protocols, which signifies the potential impact of the developed technology,'' said Rabin.


Contact: Chriss Swaney
Carnegie Mellon University

Related biology news :

1. Carnegie Mellon researchers create fluorescent biosensor to aid in drug development
2. Carnegies Doug Koshland elected to National Academy of Sciences
3. Carnegies Chris Field elected to American Academy of Arts & Sciences
4. Carnegie Mellon researchers seek to control blood loss
5. Carnegie Mellons Sanna Gaspard named New Face of Engineering
6. Carnegie Mellon first to measure energy released from a virus during infection
7. Carnegie Mellons John Kitchin receives early career award
8. Carnegie Mellons Philip LeDuc discovers new protein function
9. Carnegie Mellon engineers develop machine that visually inspects and sorts strawberry plants
10. Carnegie Mellon researchers receive grant
11. Carnegie Mellon customizing electric cars for cost-effective urban commuting
Post Your Comments:
(Date:5/12/2016)... -- , a brand of Troubadour Research ... the Q1 wave of its quarterly wearables survey. A ... to a program where they would receive discounts for ... "We were surprised to see that so ... , CEO of Troubadour Research, "primarily because there are ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a ... the MegaMatcher Automated Biometric Identification System (ABIS) ... large-scale multi-biometric projects. MegaMatcher ABIS can process multiple ... using any combination of fingerprint, face or iris ... MegaMatcher SDK and MegaMatcher Accelerator , ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Apellis ... Phase 1 clinical trials of its complement C3 ... single and multiple ascending dose studies designed to ... (PD) of subcutaneous injection in healthy adult volunteers. ... (SC) either as a single dose (ranging from ...
(Date:6/23/2016)... 23, 2016 Andrew ... Published recently in ... journal from touchONCOLOGY, Andrew D Zelenetz , ... cancer care is placing an increasing burden on ... biologic therapies. With the patents on many biologics ...
(Date:6/23/2016)... San Francisco, CA (PRWEB) , ... June 23, ... ... capture (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase ... DIA Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting ...
(Date:6/23/2016)... Connecticut (PRWEB) , ... June 23, 2016 , ... ... introduce a new line of intelligent tools designed, tuned and optimized exclusively for ... September 12–17 in Chicago. The result of a collaboration among several companies with ...
Breaking Biology Technology: